BRD2 and adenoma: GLI1 expression levels were significantly elevated in ACTH-, GH- and PRL-expressing adenomas (p = 0.026; p = 0.035; p = 0.0059, respectively) whereas null cell adenomas and FSH-expressing tumors showed similar GLI1 expression levels compared to normal adenopituitary lobes (Fig. 5a).